Announced Fri, 9 May · 09:50 IST

Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 08,2025.

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Citigroup Global Markets, acting as Manager to the Open Offer, has disclosed the number of shares tendered by public shareholders of Sanofi Consumer Healthcare India Limited as of May 8, 2025. The Open Offer is for acquisition of up to 59,87,962 equity shares (26% of voting share capital) by Opal Bidco SAS together with Clayton, Dubilier & Rice Fund XII, L.P. as persons acting in concert. A total of 23,96,014 equity shares have been tendered so far, representing 40.01% of the Offer Size, of which 1,22,355 shares (2.04% of the Offer Size) were tendered on May 8, 2025 alone. The tendered shares will undergo validation, and the number of shares validly accepted may differ from the total tendered.

Likely market impact

Moderate tendering response (40% of offer size) suggests public shareholders are partially participating in the Open Offer. Final acceptance will follow SEBI (SAST) Regulations; shareholders who have not tendered yet may still have a window to participate before the offer closes.